
1. mol neurodegener. 2016 jan 12;11:5. doi: 10.1186/s13024-016-0070-y.

alzheimer's disease-like app processing wild-type mice identifies synaptic
defects initial steps disease progression.

audrain m(1)(2)(3), fol r(1)(2)(3), dutar p(4), potier b(4), billard jm(4),
flament j(3)(5), alves s(1)(3), burlot ma(1)(2)(3), dufayet-chaffaud g(1)(3),
bemelmans ap(3)(6), valette j(3)(6), hantraye p(3)(5)(6), déglon n(7)(8), cartier
n(9)(10), braudeau j(1)(3).

author information: 
(1)inserm umr1169, université paris-sud, université paris-saclay, orsay, 94100,
france.
(2)université paris descartes, paris, france.
(3)cea, dsv, i2bm, mircen, fontenay-aux-roses, 92265, france.
(4)inserm umr894, centre de psychiatrie et neurosciences, université paris
descartes, sorbonne paris cité, paris, france.
(5)inserm ums27, fontenay-aux-roses 92265, université paris-sud, université
paris-saclay, orsay, 94100, france.
(6)cnrs umr9199, fontenay-aux-roses 92265, université paris-sud, université
paris-saclay, orsay, 94100, france.
(7)department clinical neurosciences, laboratory cellular molecular
neurotherapies, lausanne university hospital, lausanne, switzerland.
(8)neuroscience research center, laboratory cellular molecular
neurotherapies, lausanne university hospital, lausanne, switzerland.
(9)inserm umr1169, université paris-sud, université paris-saclay, orsay, 94100,
france. nathalie.cartier@inserm.fr.
(10)cea, dsv, i2bm, mircen, fontenay-aux-roses, 92265, france.
nathalie.cartier@inserm.fr.

background: alzheimer's disease (ad) frequent form dementia the
elderly effective treatment currently available. mechanisms
triggering ad onset progression still imperfectly dissected. aimed 
deciphering modifications occurring vivo early stages of
ad, development amyloid deposits, neurofibrillary tangles, neuronal
death inflammation. current ad models based amyloid precursor protein
(app) overproduction beginning utero, rapidly reproduce the
histological behavioral features disease within months, 
appropriate study early steps ad development. means mimic in
vivo amyloid app processing closer human situation ad, used an
adeno-associated virus (aav)-based transfer human mutant app presenilin 1 
(ps1) genes hippocampi two-month-old c57bl/6 j mice express human
app, without significant overexpression specifically induce amyloid
processing.
results: human app, βctf aβ42/40 ratio similar in
hippocampal tissues ad patients. three months injection murine tau
protein hyperphosphorylated rapid synaptic failure occurred characterized
by decreased levels psd-95 metabolites related neuromodulation, on
proton magnetic resonance spectroscopy ((1)h-mrs). astrocytic glt-1 transporter
levels lower tonic glutamatergic current stronger on
electrophysiological recordings ca1 hippocampal region, revealing the
overstimulation extrasynaptic n-methyl d-aspartate receptor (nmdar) which
precedes loss long-term potentiation (ltp). modifications were
associated early behavioral impairments open-field, y-maze morris
mater maze tasks.
conclusions: altogether, demonstrates ad-like app processing,
yielding levels app, βctf aβ42/aβ40 ratio similar observed 
ad patients, sufficient rapidly trigger early steps amyloidogenic
and tau pathways vivo. strategy, identified sequence early
events likely account disease onset described model may
facilitate efforts decipher factors triggering ad evaluate early
neuroprotective strategies.

doi: 10.1186/s13024-016-0070-y 
pmcid: pmc4709894
pmid: 26759118  [indexed medline]

